Evaluation of the Commercial Rapid Trehalose Test (GLABRATA RTT) for the Point of Isolation Identification of Candida glabrata Isolates in Primary Cultures

Mycopathologia

Volumn 173, Issue 4, 2012, Pages 259-264

  Fraser, Mark ^a   Borman, Andrew M ^a   Johnson, Elizabeth M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Candida glabrata; Candidaemia; Identification; Point of isolation identification; Rapid trehalose test

Indexed keywords

TREHALOSE;

ANALYTICAL EQUIPMENT; ARTICLE; CANDIDA GLABRATA; CANDIDIASIS; DIAGNOSTIC PROCEDURE; EVALUATION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; MYCOLOGY;

CANDIDA GLABRATA; CANDIDIASIS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; MYCOLOGY; REAGENT KITS, DIAGNOSTIC; TREHALOSE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 84857898630     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9508-5     Document Type: Article

References (29)

1. Ruhnke M. Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets. 2006; 7: 495-504.
2. Wright WL, Wenzel RP. Nosocomial Candida. Epidemiology, transmission and prevention. Infect Dis Clin N Am. 1997; 11: 411-25.
3. Krcmery V, Barnes AJ. Non-albicansCandida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002; 54: 243-60.
4. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to Candida albicans. Clin Microbiol Rev. 1999; 12: 80-9.
5. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48: 503-35.
6. Sheppard DC, Locas MC, Restieri C, Laverdiere M. Utility of the germ tube test for direct identification of Candida albicans from positive blood culture bottles. J Clin Microbiol. 2008; 46: 3508-9.
7. Sanguinetti M, Porta R, Sali M, La Sorda M, Pecorini G, Fadda G, Posteraro B. Evaluation of VITEK2 and RapID Yeast Plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol. 2007; 45: 1343-6.
8. Wadlin JK, Hanko G, Stewart R, Pape J, Nachamkin I. Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. J Clin Microbiol. 1999; 37: 1967-70.
9. Smith MB, Dunklee D, Vu H, Woods GL. Comparative performance of the RapID Yeast Plus system and the API 20C AUX clinical yeast system. J Clin Microbiol. 1999; 37: 2697-8.
10. Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J Clin Microbiol. 2007; 45: 1087-92.
11. Graf B, Adam T, Zill E, Göbel UB. Evaluation of the VITEK 2 system for the rapid identification of yeasts and yeast-like organisms. J Clin Microbiol. 2000; 38: 1782-5.
12. Espinel-Ingroff A, Stockman L, Roberts G, Pincus D, Pollack J, Marler J. Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin Microbiol. 1998; 36: 883-6.
13. Campbell CK, Davey KG, Holmes AD, Szekely A, Warnock DW. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin Microbiol. 1999; 37: 821-3.
14. Fenn JP, Billetdeaux E, Segal H, Skodack-Jones L, Padilla PE, Bale M, Carroll K. Comparison of four methodologies for the rapid and cost-effective identification of Candida glabrata. J Clin Microbiol. 1999; 37: 3387-9.
15. Borman AM, Petch R, Linton CJ, Palmer MD, Bridge PD, Johnson EM. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol. 2008; 46: 933-8.
16. Bishop JA, Chase N, Magill SS, Kurtzman CP, Fiandaca MJ, Merz WG. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection. J Clin Microbiol. 2008; 46: 443-6.
17. Linton CJ, Borman AM, Cheung G, Holmes AD, Szekely A, Palmer MD, Bridge PD, Campbell CK, Johnson EM. Molecular identification of unusual pathogenic yeast isolates by Large Ribosomal Subunit gene sequencing: 2 years experience at the UK Mycology Reference Laboratory. J Clin Microbiol. 2007; 45: 1152-8.
18. Freydiere AM, Guinet R, Boiron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol. 2001; 39: 9-33.
19. Kirdar S, Gültekin B, Evcil G, Ozkütük A, Aydin N. Evaluation of a rapid trehalase test for the identification of Candida glabrata. Mikrobiyol Bul. 2009; 43: 303-7.
20. Willinger B, Wein S, Hirschl AM, Rotter ML, Manafi M. Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identification of Candida glabrata. J Clin Microbiol. 2005; 43: 499-501.
21. Freydiere AM, Perry JD, Faure O, Willinger B, Tortorano AM, Nicholson A, Peman J, Verweij PE. Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories. J Clin Microbiol. 2004; 42: 4870-2.
22. Freydiere AM, Robert R, Ploton C, Marot-Leblond A, Monerau F, Vandenesch F. Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTT. J Clin Microbiol. 2003; 41: 3861-3.
23. Peltroche-Llacsahuanga H, Schnitzler N, Lütticken R, Haase G. Rapid identification of Candida glabrata by using a dipstick to detect trehalase-generated glucose. J Clin Microbiol. 1999; 37: 202-5.
24. Piens MA, Perry JD, Raberin H, Parant F, Freydière AM. Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories. J Clin Pathol. 2003; 56: 687-9.
25. Parant F, Freydiere AM, Gille Y, Boiron P, Odds FC. A "one minute" trehalase detection test for the identification of Candida glabrata. J Mycol Med. 2001; 11: 26-31.
26. Montero CI, Shea YR, Jones PA, Harrington SM, Tooke NE, Witebsky FG, Murray PR. Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur J Clin Microbiol Infect Dis. 2008; 27: 821-30.
27. ® analysis of 35 nucleotides of the Internal Transcribed Spacer 2. J Clin Microbiol. 2010; 48: 3648-53.
28. Marklein G, Josten M, Klanke U, Müller E, Horré R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol. 2009; 47: 2912-7.
29. Quiles-Melero I, García-Rodríguez J, Gómez-López A, Mingorance J. Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis. Eur J Clin Microbiol Infect Dis. 2012; 31: 67-71.